Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-07-014442
Filing Date
2007-02-27
Accepted
2007-02-27 16:41:46
Documents
11
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a07-1805_110k.htm 10-K 1997177
2 EXECUTIVE COMPENSATION TABLE a07-1805_1ex10d26.htm EX-10.26 49420
3 DIRECTOR COMPENSATION TABLE a07-1805_1ex10d27.htm EX-10.27 39611
4 SUBSIDIARIES OF THE REGISTRANT a07-1805_1ex21d1.htm EX-21.1 5771
5 CONSENT OF DELOITTE & TOUCHE LLP a07-1805_1ex23d1.htm EX-23.1 3675
6 CONSENT OF BDO SEIDMAN, LLP a07-1805_1ex23d2.htm EX-23.2 4221
7 CERTIFICATION OF CEO AND PRESIDENT a07-1805_1ex31d1.htm EX-31.1 15982
8 CERTIFICATION OF CFO a07-1805_1ex31d2.htm EX-31.2 17501
9 CERTIFICATION OF CEO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 a07-1805_1ex32d1.htm EX-32.1 6590
10 CERTIFICATION OF CFO PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 a07-1805_1ex32d2.htm EX-32.2 7711
11 GRAPHIC g18051dgi001.gif GRAPHIC 11293
  Complete submission text file 0001104659-07-014442.txt   2164912
Mailing Address FIVE CONCOURSE PARKWAY SUITE 1800 ATALANTA GA 30328
Business Address FIVE CONCOURSE PARKWAY SUITE 1800 ATALANTA GA 30328 678-341-1436
SCIELE PHARMA, INC. (Filer) CIK: 0001106773 (see all company filings)

EIN.: 582004779 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-30123 | Film No.: 07653775
SIC: 2834 Pharmaceutical Preparations